Compare ITRG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRG | ANGO |
|---|---|---|
| Founded | 1997 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.9M | 420.2M |
| IPO Year | 2017 | 2004 |
| Metric | ITRG | ANGO |
|---|---|---|
| Price | $2.24 | $11.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $5.75 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 1.5M | 997.3K |
| Earning Date | 11-11-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $19.41 | $5.47 |
| Revenue Next Year | $26.85 | $5.10 |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $1.99 | $9.39 |
| 52 Week High | $4.87 | $16.29 |
| Indicator | ITRG | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 39.83 |
| Support Level | $2.00 | $11.60 |
| Resistance Level | $2.30 | $12.50 |
| Average True Range (ATR) | 0.11 | 0.51 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 46.27 | 24.80 |
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.